Bone Balancer

Most people start losing bone in their 30's. And most women wind up with osteoporosis. Here's safe and essential support to complement the exercise, calcium, soy, phyto-estrogens and any prescription drugs in the battle against bone loss. Dr. Geiger's blend of sage, rosemary, thyme, juniper, pine and eucalyptus oils was inspired by a study showing that they strongly inhibit the bone cell activity that causes bone loss. Regular use of this blend in a non-scented body lotion could potentially help preserve existing bone and facilitate new bone formation.

The health of the human skeleton can be modified by integrating aids to general health. A simple routine of exercises such as walking, weight training and stretching promotes stronger bones. Secondary plant metabolites from therapeutic essential oils are a natural source of support, complementing supplementation with calcium, soy and the phyto-estrogens.

Consider that this blend of essential oils from common herbs by the oilMD contains certain essential oils determined in one non human study to inhibit the type of bone cell called osteoclasts which cause bone reabsorption.

 Mentally guide yourself towards a positive bone balance with the daily external application of the therapeutic grade essential oils in Bone Balancer from the oilMD.

The Bone Balancer Blend by the oilMD provides non-medicated comfort and does not replace taking prescribed medications and the following scientific references which are intended for educational purposes only are not for diagnosis, treatment or to prevent any disease.

All the oilMD essential oil blends are estrogen receptor and U.V light safe.

Scientific references for the Integrative aromatherapy features of Bone Balancer for the skeletal system:

Barnes, S., (2003).Phyto-oestrogens and osteoporosis: what is a safe dose? Br J Nutr. Jun;89 Suppl 1:S101-8.

Cassidy, A., (2003). Potential risks and benefits of phytoestrogen-rich diets. Int J Vitam Nutr Res. Mar; 73(2):120-6.

Davis, S.R., O’Neill, S.M., Eden, J., Baber, R., Ekangaki, A., Stocks, J.M., & Thiebaud, D., (2004). Transition from estrogen therapy to raloxifene in postmenopausal women: effects on treatment satisfaction and the endometrium-a pilot study. Menopause. Mar-Apr; 11(2):167-75.

Eden, JA. (2001). Managing the menopause: phyto-oestrogens or hormone replacement therapy? Ann Med. Feb; 33(1):4-6.

Gallagher, J.C., (1999).Moderation of the daily dose of HRT: prevention of osteoporosis. Maturitas. Nov; 33 Suppl 1:S57-63.

Howes, M.J., Houghton, P.J., Barlow, D.J., Pocock, V.J., & Milligan, S.R., (2002). Assessment of estrogenic activity in some common essential oil constituents. J Pharm Pharmacol. Nov; 54(11):1521-8.

Kardinaal, A.F., Morton, M.S., Bruggemann-Rotgans, I.E., & van Beresteijn, E.C., (1998).Phyto-oestrogen excretion and rate of bone loss in postmenopausal women. Eur J Clin Nutr. Nov; 52(11):850-5.

Muhlbauer, R.C., Lozano, A., Palacio, S., Reinli, A., & Felix, R., (2003).Common herbs, essential oils, and monoterpenes potently modulate bone metabolism. Bone. Apr;32(4):372-80.

Santoyo, S., Cavero, S., Jaime, L., Ibanez, E., Senorans, F.J., & Reglero, G., ( 2005). Chemical composition and antimicrobial activity of Rosmarinus officinalis L. essential oil obtained via supercritical fluid extraction. J Food Prot. Apr; 68(4):790-5.

Singh, B., Bhat, T.K., & Singh, B., (2003). Potential therapeutic applications of some antinutritional plant secondary metabolites. J Agric Food Chem. Sep 10; 51(19):5579-97.

Tabanca, N., Khan, S.I., Bedir, E., Annavarapu, S., Willett, K., Khan, I.A, Kirimer N., Husnu, Can Baser K., (2004). Estrogenic activity of isolated compounds and essential oils of Pimpinella species from Turkey, evaluated using a recombinant yeast screen. Planta Med. Aug; 70(8):728-35.

Waddell, W.J., (2002). Thresholds of carcinogenicity of flavors. Toxicol Sci. Aug; 68(2):275-9.

Zhang, D., & Zhang, R.J., (2005). Ozonolysis of alpha-pinene and beta-pinene: Kinetics and mechanism. Chem Phys. Mar; 122(11):114308.

Customer Reviews: